Ethic Inc. Has $1.18 Million Stock Holdings in Omega Healthcare Investors, Inc. $OHI

Key Points

• Ethic Inc. increased its stake in Omega Healthcare Investors by 162.1%, now owning 30,896 shares valued at approximately $1.18 million.
• Omega Healthcare reported earnings of $0.77 per share for the latest quarter, surpassing estimates significantly by $0.32.
• The company announced a quarterly dividend of $0.67, reflecting an annualized yield of 6.5%, though it reported a high payout ratio of 165.43%.

Ethic Inc. raised its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 162.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,896 shares of the real estate investment trust's stock after buying an additional 19,108 shares during the quarter. Ethic Inc.'s holdings in Omega Healthcare Investors were worth $1,176,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. NBC Securities Inc. bought a new stake in Omega Healthcare Investors in the 1st quarter valued at $29,000. Dunhill Financial LLC grew its holdings in shares of Omega Healthcare Investors by 97.9% in the 4th quarter. Dunhill Financial LLC now owns 1,516 shares of the real estate investment trust's stock worth $57,000 after purchasing an additional 750 shares during the last quarter. CoreCap Advisors LLC grew its holdings in shares of Omega Healthcare Investors by 177.3% in the 4th quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after purchasing an additional 1,009 shares during the last quarter. Park Square Financial Group LLC bought a new stake in shares of Omega Healthcare Investors in the 4th quarter worth about $61,000. Finally, UMB Bank n.a. grew its holdings in shares of Omega Healthcare Investors by 94.9% in the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock worth $83,000 after purchasing an additional 1,059 shares during the last quarter. Institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Price Performance

NYSE:OHI traded down $0.16 during mid-day trading on Friday, reaching $42.20. 1,505,971 shares of the company were exchanged, compared to its average volume of 2,310,337. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42. The company has a fifty day moving average of $38.50 and a 200 day moving average of $37.61. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a market cap of $12.45 billion, a PE ratio of 26.05, a PEG ratio of 2.24 and a beta of 0.66.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same period in the prior year, the company posted $0.71 EPS. The company's revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.4%. Omega Healthcare Investors's dividend payout ratio is presently 165.43%.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Royal Bank Of Canada upped their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a report on Thursday, August 7th. Wells Fargo & Company raised shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $38.00 to $41.00 in a report on Monday, July 14th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has a consensus rating of "Hold" and a consensus price target of $42.00.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.